The Center for Cancer
The Center for Genetics
The Center for Immunobiology & Vaccine Development:
The Center for Nutrition & Metabolism
The Center for Prevention of Obesity, Cardiovascular Disease & Diabetes
The Center for Sickle Cell Disease & Thalassemia





CHORI Staff Directory
CHORI Intranet
 
tumor
Providing the Power to Cure
Translational and Clinical Research in CHORI's Center for Cancer

Our interactions with the researchers gives them ideas of how their research might actually translate into doing something for the child.
CHORI’s Center for Cancer Research is uniquely positioned to foster the dynamic collaboration between clinicians, clinical researchers and basic scientists necessary for developing cutting-edge translational research.

A member of the Children’s Oncology Group (COG) – the largest cooperative pediatric clinical trials group in the nation – CHORI’s Center for Cancer clinical oncology department designs, monitors and implementats clinical and translational research aimed at improving the long term outcome of all children with malignant tumors.

The director of Children Hospital Oakland’s (CHO) nationally renowned Oncology Department, James Feusner, MD, is responsible for the major translational research efforts of The Center for Cancer Research. Since 1979, Dr. Feusner has been an active member of COG, which was created specifically to conduct clinical trials and translational research for children with cancer and represents the management of nearly 90 percent of children’s clinical cancer research in the nation. Dr. Feusner’s current research interests include hepatoblastoma in premature babies, promyelocytic leukemia and ongoing epidemiologic studies related to the incidence of brain tumors and leukemia in California children.
Their work gets us excited about what might be going on in the patient that we can’t see. It really is cross-fertilization. - James Feusner, MD
 Director of the Children’s Hospital Oakland (CHO) Human Leukocyte Antigen (HLA) Clinical Laboratory and diplomat of the American Board of Histocompatibility and Immunogenetics (ABHI), Elizabeth Trachtenberg, PhD, investigates the roles of HLA and Natural Killer Immunoglobulin-like Receptor (KIR) complexes in stem cell transplantation outcome. Under Dr. Trachtenberg’s direction, the HLA lab is one of four laboratories in the nation that act as ASHI/CAP referees for HLA class I and class II DNA and serological tying proficiency surveys.

These are but two examples of The Center for Cancer Research’s dedication to translational and clinical research aimed at cancer prevention, treatment and enhanced quality of life. Explore the Investigator links in the sidebar menu to discover all the ways in which CHORI’s Center for Cancer
Research is at the forefront of cancer treatment and research, offering unparalleled access to all diagnostic and treatment regimens available while providing the highest quality in patient care.

© 2005 Children's Hospital Oakland Research Institute
5700 Martin Luther King Jr Way • Oakland, California 94609
Phone 510-450-7600 • Fax 510-450-7910
Site Map • Disclaimer • CHORI Intranet • Email Webmaster